These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 17220349)

  • 1. Papillary thyroid cancer and polymorphic variants in TSHR- and RET-related genes: a nested case-control study within a cohort of U.S. radiologic technologists.
    Lönn S; Bhatti P; Alexander BH; Pineda MA; Doody MM; Struewing JP; Sigurdson AJ
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):174-7. PubMed ID: 17220349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible Impact of RET Polymorphism and Its Haplotypic Association Modulates the Susceptibility to Thyroid Cancer.
    Khan MS; Pandith AA; Iqbal M; Naykoo NA; Khan SH; Rather TA; Mudassar S
    J Cell Biochem; 2015 Aug; 116(8):1712-8. PubMed ID: 25736215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RET/PTC rearrangements preferentially occurred in papillary thyroid cancer among atomic bomb survivors exposed to high radiation dose.
    Hamatani K; Eguchi H; Ito R; Mukai M; Takahashi K; Taga M; Imai K; Cologne J; Soda M; Arihiro K; Fujihara M; Abe K; Hayashi T; Nakashima M; Sekine I; Yasui W; Hayashi Y; Nakachi K
    Cancer Res; 2008 Sep; 68(17):7176-82. PubMed ID: 18757433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Frequency of RET/PTC rearrangement and somatic BRAF mutation in papillary thyroid cancer].
    Rumiantsev PO; Zaletaev DV; Vasil'ev EV; Saenko VA; Il'in AA; Rumiantseva UV; Abrosimov AIu; Medvedev VS
    Vopr Onkol; 2006; 52(2):145-9. PubMed ID: 17195637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The involvement of the RET variant G691S in medullary thyroid carcinoma enlightened by a meta-analysis study.
    Lantieri F; Caroli F; Ceccherini I; Griseri P
    Int J Cancer; 2013 Jun; 132(12):2808-19. PubMed ID: 23180660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of RET variants G691S, L769L, S836S and S904S to sporadic medullary thyroid cancer.
    Machens A; Frank-Raue K; Lorenz K; Rondot S; Raue F; Dralle H
    Clin Endocrinol (Oxf); 2012 May; 76(5):691-7. PubMed ID: 22111543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of circulating thyroid cancer cells in patients with thyroid microcarcinomas.
    Novosel T; Ritter HE; Gupta M; Harvey A; Mitchell J; Berber E; Siperstein A; Milas M
    Surgery; 2009 Dec; 146(6):1081-9. PubMed ID: 19958935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer.
    Romei C; Ciampi R; Faviana P; Agate L; Molinaro E; Bottici V; Basolo F; Miccoli P; Pacini F; Pinchera A; Elisei R
    Endocr Relat Cancer; 2008 Jun; 15(2):511-20. PubMed ID: 18509003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RET genotypes in sporadic medullary thyroid cancer: studies in a large Italian series.
    Fugazzola L; Muzza M; Mian C; Cordella D; Barollo S; Alberti L; Cirello V; Dazzi D; Girelli ME; Opocher G; Beck-Peccoz P; Persani L
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):418-25. PubMed ID: 18284634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RET polymorphisms and haplotypes and risk of differentiated thyroid cancer.
    Ho T; Li G; Zhao C; Wei Q; Sturgis EM
    Laryngoscope; 2005 Jun; 115(6):1035-41. PubMed ID: 15933516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the RET variant G691S influence the features of sporadic medullary thyroid carcinoma?
    Cardot-Bauters C; Leteurtre E; Leclerc L; Vantyghem MC; Do Cao C; Wemeau JL; d'Herbomez M; Carnaille B; Barbu V; Pinson S; Pigny P;
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):506-10. PubMed ID: 18331611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RET oncogene amplification in thyroid cancer: correlations with radiation-associated and high-grade malignancy.
    Nakashima M; Takamura N; Namba H; Saenko V; Meirmanov S; Matsumoto N; Hayashi T; Maeda S; Sekine I
    Hum Pathol; 2007 Apr; 38(4):621-8. PubMed ID: 17270245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of RET genetic polymorphisms and haplotypes with papillary thyroid carcinoma in the Portuguese population: a case-control study.
    Santos M; Azevedo T; Martins T; Rodrigues FJ; Lemos MC
    PLoS One; 2014; 9(10):e109822. PubMed ID: 25330015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rearrangement analysis in archival thyroid tissues: punching microdissection and artificial RET/PTC 1-12 transcripts.
    Imkamp F; von Wasielewski R; Musholt TJ; Musholt PB
    J Surg Res; 2007 Dec; 143(2):350-63. PubMed ID: 17655865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation induced thyroid cancer: fundamental and applied aspects.
    Tronko M; Bogdanova T; Voskoboynyk L; Zurnadzhy L; Shpak V; Gulak L
    Exp Oncol; 2010 Sep; 32(3):200-4. PubMed ID: 21403618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns)).
    Carta C; Moretti S; Passeri L; Barbi F; Avenia N; Cavaliere A; Monacelli M; Macchiarulo A; Santeusanio F; Tartaglia M; Puxeddu E
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):105-9. PubMed ID: 16402937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RET proto-oncogene expression of papillary thyroid carcinomas in Thai patients.
    Keelawat S; Shuangshoti S; Assanasen T; Thanakit V; Ruangvejvorachai P; Poumsuk U; Wannakrairot P
    J Med Assoc Thai; 2006 Sep; 89 Suppl 3():S5-12. PubMed ID: 17718263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of thyroid-stimulating hormone receptor mRNA with real-time PCR for early diagnosis of papillary thyroid microcarcinoma.
    Qiu J; Zhang Y; Guo X; Zeng F; Zhao C; Qiu X; Wu X
    Neoplasma; 2010; 57(4):360-4. PubMed ID: 20429628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RET exon 11 (G691S) polymorphism is significantly more frequent in sporadic medullary thyroid carcinoma than in the general population.
    Elisei R; Cosci B; Romei C; Bottici V; Sculli M; Lari R; Barale R; Pacini F; Pinchera A
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3579-84. PubMed ID: 15240649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The RET polymorphic allele S836S is associated with early metastatic disease in patients with hereditary or sporadic medullary thyroid carcinoma.
    Siqueira DR; Romitti M; da Rocha AP; Ceolin L; Meotti C; Estivalet A; Puñales MK; Maia AL
    Endocr Relat Cancer; 2010 Dec; 17(4):953-63. PubMed ID: 20801952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.